pentobarbital will reduce the extent or impact of bedaquiline by affecting hepatic/intestinal enzyme CYP3A4 metabolism. Steer clear of or Use Alternate Drug. Steer clear of coadministration of bedaquiline with robust CYP3A4 inducers due to probable for reduced therapeutic influencepentobarbital will minimize the level or influence of etonogestrel b